Biochemical studies in early infantile autism

Area of Science:

• Biochemistry
• Psychiatry
• Genetics

Background:

• N, N-dimethyltryptamines (N, N-DMT) are endogenous compounds with potential psychoactive properties.
• Previous research has explored the role of various substances in psychiatric disorders.
• Bufotenin, a related compound, has also been investigated in relation to neurological conditions.

Purpose of the Study:

• To investigate the presence of N, N-DMT in the urine of schizophrenic patients and normal controls.
• To examine N, N-DMT and bufotenin levels in children with early infantile autism and their parents.
• To determine if psychopathology is a prerequisite for bufotenin positivity.

Main Methods:

• Urine analysis was conducted on schizophrenic patients, individuals with early infantile autism, and normal controls.
• Psychiatric assessments including the Psychiatric Assessment Interview, Minnesota Multiphasic Personality Index, and Rorschach were performed.
• Analysis for bufotenin was performed on autistic children and their parents.

Main Results:

• All schizophrenic patients and children with early infantile autism tested positive for N, N-DMT, while none of the normal controls did.
• Seven out of ten parents of autistic children were positive for bufotenin, despite showing no psychopathology.
• Bufotenin was detected in 6 out of 18 autistic children.

Conclusions:

• The excretion of N, N-DMT appears to be a distinguishing factor between schizophrenic/autistic individuals and healthy controls.
• Bufotenin positivity can occur in individuals without apparent psychopathology, suggesting a potential genetic predisposition in families with autism.
• Further research is warranted to explore the role of these compounds in the etiology of psychiatric and developmental disorders.